We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

12 hedge funds and large institutions have $1.1M invested in Acer Therapeutics Inc in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less capital invested

Capital invested by funds: $1.18M → $1.1M (-$80.5K)

25% less funds holding

Funds holding: 1612 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
7
Calls
Puts
Net Calls
Net Calls Change

ACER Hedge Fund Activity: Q3 2015 in Review

12 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2015, worth a combined $1.1M — down 6.8% from $1.18M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACER and 3 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $105K. The largest seller was Citadel Advisors, exiting entirely with an estimated $68K sold.

  • 12 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2015, down from 16 in Q2 2015.
  • Funds reported $1.1M of Acer Therapeutics Inc stock for Q3 2015, down 6.8% quarter-over-quarter.
  • 3 funds opened new Acer Therapeutics Inc positions in Q3 2015 and 7 closed out, a net change of -4 holders.
  • The largest Acer Therapeutics Inc buyer in Q3 2015 was Renaissance Technologies, an estimated $105K added.
  • The largest Acer Therapeutics Inc seller in Q3 2015 was Citadel Advisors, an estimated $68K sold.

Based on aggregated 13F filings for Q3 2015.